Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769275 · ClinicalTrials.gov registry record
Detection of Ischemia in Asymptomatic Diabetics
A clinical trial of Type 2 Diabetes Mellitus, sponsored by Yale University.
- Completed
- Registry status
- 1,123
- Enrollment target
- 1
- Study location
NCT00769275 is a study of Type 2 Diabetes Mellitus that has completed, run by Yale University. The registered enrollment target is 1,123 participants, below the 2,739-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00769275, a study of Type 2 Diabetes Mellitus, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 1,123 participants
- Enrollment target
- 1
- Study location
Study Summary
Asymptomatic subjects with Type 2 Diabetes Mellitus were randomized to either screening with Tc-99m sestamibi adenosine SPECT imaging or no screening. All patients will be followed for 5 years for the occurrence of cardiac death or non-fatal myocardial infarction. The aims are: 1. To prospectively assess the prevalence of silent myocardial ischemia in asymptomatic subjects with Type 2 Diabetes Mellitus. 2. To identify on the basis of clinical and/or biochemical variables in a high-risk cohort in which screening for coronary artery disease is appropriate. 3. To assess progression of (silent) myocardial ischemia after 3 years. 4. To assess the occurence of cardiac death or nonfatal myocardial infarction during 5 years follow-up in screened and not screened subjects.
Conditions Studied
Study Locations (1)
Connecticut
- Yale University School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,123 participants |
| Start Date | 2000-08 |
| Est. Completion | 2008-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00769275
The ClinicalTrials.gov registry entry for NCT00769275 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,739-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (59% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT00769275 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00769275 about?
NCT00769275 is a clinical study titled "Detection of Ischemia in Asymptomatic Diabetics". Asymptomatic subjects with Type 2 Diabetes Mellitus were randomized to either screening with Tc-99m sestamibi adenosine SPECT imaging or no screening. All patients will be followed for 5 years for the occurrence of cardiac death or non-fatal myocardial infarction. The aims are: 1. To prospectively...
What is the current status of trial NCT00769275?
This trial is currently completed. The enrollment target is 1,123 participants. The study started on 2000-08. Estimated completion is 2008-01.
What conditions does trial NCT00769275 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
Who is sponsoring clinical trial NCT00769275?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00769275 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
RECRUITING
-
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
-
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
RECRUITING
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
RECRUITING
-
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.